140 related articles for article (PubMed ID: 8122184)
1. Antithrombin-III plasma activity during and after prolonged use of heparin in unstable angina.
Lidón RM; Théroux P; Robitaille D
Thromb Res; 1993 Oct; 72(1):23-32. PubMed ID: 8122184
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
3. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris.
Yasu T; Oshima S; Imanishi M; Nonogi H; Haze K; Kuramochi M; Omae T; Hayashi Y; Yamamoto S
Am J Cardiol; 1993 May; 71(13):1164-8. PubMed ID: 8480641
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
5. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
8. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
Meyer D; Tsakiris DA; Marbet GA
Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
[TBL] [Abstract][Full Text] [Related]
9. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
11. Coagulation activity and clinical outcome in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
[TBL] [Abstract][Full Text] [Related]
12. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
[TBL] [Abstract][Full Text] [Related]
13. Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III.
Leclerc JR; Geerts W; Panju A; Nguyen P; Hirsh J
Thromb Res; 1986 Feb; 41(4):567-73. PubMed ID: 3961735
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
[TBL] [Abstract][Full Text] [Related]
15. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
Oshima S; Uchida K; Yasu T; Uno K; Nonogi H; Haze K
Arterioscler Thromb; 1991; 11(6):1772-7. PubMed ID: 1834167
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
Marco J; Ariëns RA; Fajadet J; Bossi IM; Marco I; Bernies M; Romano SM; Donatelli F; Brambilla GM; Somalvico F; Mari D; Gregorini L
Am J Cardiol; 2000 Mar; 85(5):527-31. PubMed ID: 11078261
[TBL] [Abstract][Full Text] [Related]
17. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
19. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
Kussmann J; Hirche H; Sengupta R
Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
[TBL] [Abstract][Full Text] [Related]
20. Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Bijsterveld NR; Moons AH; Meijers JC; Tijssen JG; Büller HR; Levi M; Peters RJ
J Am Coll Cardiol; 2002 Mar; 39(5):811-7. PubMed ID: 11869846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
